RxDoctor Payments Data

Nicole Leger

Nurse Practitioner · Taunton, MANPI 1013296169

Payments from drug & device makers

$1,398in general payments, 2019–2025

Across 58 payments — averaging $24.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$276
  • AstraZeneca$193
  • Johnson & Johnson$137
  • GSK$115
  • Inspire Medical Systems, Inc.$113
  • Exact Sciences$103
  • plus $462 from 11 others

What the payments were for

  • Food & beverage$1,398100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,398 in reported general payments places this provider in the 90th percentile of 3,855 nurse practitioner providers in Massachusetts.

See all nurse practitioner providers in Massachusetts

Medicare billing

Part B allowed, 2024
$91,799
Medicare patients
262
Services billed
1,290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin54$83,438
EliquisApixaban55$82,842
FarxigaDapagliflozin Propanediol37$45,102
MounjaroTirzepatide23$23,675
TrulicityDulaglutide18$19,039
Rosuvastatin Calcium349$14,645
Breo ElliptaFluticasone/Vilanterol14$6,579
Arnuity ElliptaFluticasone Furoate19$5,255
Atorvastatin Calcium308$4,174
Metoprolol Succinate231$4,034
Irbesartan61$2,538
Lisinopril325$2,491
Omeprazole177$2,163
Pantoprazole Sodium109$1,920
Levothyroxine Sodium234$1,669

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$66$82,84255 claims
AstraZenecaFarxiga$193$45,10237 claims
Lilly USA, LLCMounjaro, Trulicity$67$42,71441 claims
GSKBreo Ellipta, Arnuity Ellipta$115$11,83433 claims
AbbVieSynthroid$24$80734 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,855 nurse practitioner providers in Massachusetts.

Other nurse practitioner in Taunton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →